Author:
Bao Hanmei,Lv Feng,Liu Tianjun
Funder
National Natural Science Foundation of China
National Research Foundation of Tianjin (China)
Subject
Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology
Reference46 articles.
1. Management of risk in peripheral artery disease: recent therapeutic advances;Hackam;Am. Heart J.,2005
2. Management of peripheral vascular disease;Baumgartner;Annu. Rev. Med.,2005
3. Role of G-CSF and GM-CSF therapy in patients with acute myocardial infarction and critical limb ischemia;Centola;G. Ital. Cardiol. (Rome),2014
4. Current Phase II drugs under investigation for the treatment of limb ischemia;Spiliopoulos;Expert. Opin. Invest. Drugs,2015
5. Modified VEGF targets the ischemic myocardium and promotes functional recovery after myocardial infarction;Yang;J. Control. Release,2015
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献